KREBSBIO vs RPGLIFE: Stock Comparison

KREBS BIOCHEMICALS & IND vs RPG LIFE SCIENCESUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

RPG LIFE SCIENCES is the larger company by market capitalisation. KREBS BIOCHEMICALS & IND shows a lower P/E, while RPG LIFE SCIENCES shows a higher dividend yield, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

KREBSBIO leads 4; RPGLIFE leads 7 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

KREBSBIORPGLIFE

Valuation lens

What price are you paying?

Market CapContext only
₹121 Cr
₹4,515 Cr
P/E RatioKREBSBIO has the lower reading
0x
51.42x
P/B RatioKREBSBIO has the lower reading
0x
7.03x
EPSRPGLIFE has the higher reading
₹-1.15
₹18.6
Book ValueContext only
₹366.03
Dividend YieldRPGLIFE has the higher reading
0%
0.91%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
RPGLIFE is the larger company
₹4,515 Cr vs ₹121 Cr
P/E Ratio
KREBSBIO has a lower P/E
0x vs 51.42x
P/B Ratio
KREBSBIO has a lower P/B
0x vs 7.03x
EPS
RPGLIFE has higher earnings per share
₹18.6 vs ₹-1.15
Dividend Yield
RPGLIFE has a higher dividend yield
0.91% vs 0%
Revenue Growth (TTM YoY)
RPGLIFE has faster revenue growth
23.6% vs 11.6%
EPS Growth (TTM YoY)
KREBSBIO has faster EPS growth
0% vs -74.5%
Qtr Sales Growth
RPGLIFE has stronger quarterly sales growth
0% vs -70.57%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricKREBSBIORPGLIFE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricKREBSBIORPGLIFE
Live Price₹55.95₹2,721.6
Day Change2.66%2.61%
Volume5,83020,463
52-Week High₹82.49₹3,082
52-Week Low₹38.33₹1,733
Distance from 52W High-32.17%-11.69%

Valuation

MetricKREBSBIORPGLIFE
Market Cap₹121 Cr₹4,515 Cr
P/E Ratio0x51.42x
P/B Ratio0x7.03x
EPS₹-1.15₹18.6
Book Value₹366.03
Dividend Yield0%0.91%

Growth

MetricKREBSBIORPGLIFE
Revenue Growth (TTM YoY)11.6%23.6%
EPS Growth (TTM YoY)0%-74.5%
Qtr Sales Growth-70.57%0%
Qtr Profit Growth85.33%0.62%

Profitability & Leverage

MetricKREBSBIORPGLIFE
ROE19.02%
ROCE-15.89%24.39%
Net Margin-71.35%29.25%
Operating Margin-41.49%21.92%
Debt to Equity0.03x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricKREBSBIORPGLIFE
Promoter Holding72.74%72.95%
FII Holding0.5%0.95% 0.08 pp
DII Holding0%8.67% 1.22 pp
Public Holding26.76%17.42% 1.31 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: KREBS BIOCHEMICALS & IND and RPG LIFE SCIENCES.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.